Skip to content

Biosign Hcg-One Step Pregnancy Test

by Princeton Biomedix 510(k)

Active United States

510(k) K901011

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK901011 Date4 May 1990ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
JHI
Device Class
Class II
Regulation
21 CFR Part 862.1155
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The BioSign HCG One Step Pregnancy Test is a visual, prescription-use immunoassay device designed for the qualitative detection of human chorionic gonadotropin (hCG) in urine. It provides a rapid, single-step method to confirm pregnancy by identifying hCG levels above a clinically significant threshold, a key biomarker produced during early pregnancy.

This device is supplied as a single-use, non-sterile diagnostic test intended for home or clinical use. It requires no specialized equipment beyond the test cassette and a urine sample, with results visually interpreted within minutes. Regulated under FDA 510(k) clearance (K901011) and classified as a Class II device under regulation 862.1155, it adheres to Clinical Chemistry standards for pregnancy testing. No MRI safety considerations apply, and storage follows standard ambient conditions for non-sterile diagnostic tests.

Other devices from Princeton Biomedix

See all devices from Princeton Biomedix →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of settings can this pregnancy test be used in, and what does that mean for my workflow?

    The BioSign HCG-One Step Pregnancy Test is designed for both home use and clinical settings, such as doctor’s offices or labs, requiring no specialized equipment beyond the test cassette itself. Since it’s a single-use, non-sterile device, it’s ideal for point-of-care testing where rapid results are needed. Clinicians can use it for immediate patient confirmation, while patients can self-administer it at home for preliminary pregnancy verification. Results are visually interpreted within minutes, making it convenient for busy workflows.

  • Is this test reusable, or do I need to purchase multiple units for repeated testing?

    This test is intended for single-use only, meaning each cassette is designed for one test. If multiple tests are required (e.g., follow-up or retesting), you’ll need to purchase additional units. The non-sterile nature further emphasizes its one-time use to maintain accuracy and reliability.

  • How should I store this test, and what conditions are required to keep it effective?

    The BioSign HCG-One Step Pregnancy Test should be stored under standard ambient conditions, meaning no refrigeration or special temperature controls are required. It’s non-sterile, so it doesn’t need sterile storage like surgical instruments. However, keep it in a dry place and away from direct sunlight or extreme temperatures to preserve its integrity until use. Always check the expiration date before testing.

  • What does the FDA clearance (K901011) mean for the reliability of this test, and how does it differ from over-the-counter options?

    The FDA clearance under 510(k) K901011 indicates that this test has been evaluated and deemed substantially equivalent to a legally marketed device, meeting regulatory standards for accuracy, safety, and performance. Unlike over-the-counter (OTC) pregnancy tests, which are available without a prescription, this device is prescription-use only, implying it may undergo stricter validation for clinical precision. The clearance also confirms it adheres to Clinical Chemistry standards, ensuring reliability for detecting hCG levels above clinically significant thresholds.